Effectiveness and safety of ferric carboxymaltose therapy in peritoneal dialysis patients: an observational study.

Jose M PortolésBeatriz Durá-GúrpideJosé Luis Merino-RivasLeyre Martín-RodriguezCovadonga Hevia-OjangurenVictor Burguera-VionClaudia Yuste-LozanoLuisa Sánchez-GarcíaJose Ramon Rodriguez-PalomaresVicente Paraisonull null

Published in: Clinical kidney journal (2019)

In this multicentre, retrospective, real-world study conducted in the PD population, FCM was effective, safe and easy to administer during routine clinical visits.

Keyphrases

end stage renal disease
peritoneal dialysis
chronic kidney disease
ejection fraction
newly diagnosed
cross sectional
clinical trial
stem cells
prognostic factors
randomized controlled trial
patient reported outcomes
bone marrow
mesenchymal stem cells